RHINITIS, ALLERGIC
Clinical trials for RHINITIS, ALLERGIC explained in plain language.
Never miss a new study
Get alerted when new RHINITIS, ALLERGIC trials appear
Sign up with your email to follow new studies for RHINITIS, ALLERGIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Antiviral drug ganciclovir explored as new weapon against stubborn allergies
Disease control Recruiting nowThis trial investigates whether the antiviral drug ganciclovir can help people with moderate-to-severe allergic rhinitis that doesn't improve with standard treatments. Participants receive either ganciclovir capsules or a placebo for two weeks, alongside a nasal steroid spray. Re…
Matched conditions: RHINITIS, ALLERGIC
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New allergy shot aims to tame mugwort season in just four weeks
Disease control Recruiting nowThis Phase 2 trial tests PollenVax, a new immunotherapy for people with moderate-to-severe allergic rhinitis caused by mugwort pollen. The treatment is given as four weekly shots before the pollen season. Researchers will compare symptom scores and medication use between the Poll…
Matched conditions: RHINITIS, ALLERGIC
Phase: PHASE2 • Sponsor: Kazakh National Agrarian University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC